Table 4.

Proportion of well-classified patients with real datasets

	PLS+DA	PCA+DA	BGA
DLBCL	0.51(0.14)//12	0.49(0.09)//13	0.43(0.10)
Prostate	0.97(0.06)//10	0.96(0.07)//9	0.70(0.09)
ALL	0.73(0.05)//10	0.57(0.08)//1	0.60(0.06)
Leukaemia	0.97(0.03)//1	0.95(0.04)//5	0.98(0.03)

Mean (Standard deviation) over the fifty cross-validation runs for the optimal number of component (indicated after //). Results were obtained with the DLBCL, the prostate, the ALL, and the leukaemia datasets. PLS: Partial Least Squares – PCA: Principal Components Analysis – DA: Discriminant Analysis.